全文获取类型
收费全文 | 1798篇 |
免费 | 20篇 |
国内免费 | 1篇 |
专业分类
电工技术 | 12篇 |
综合类 | 5篇 |
化学工业 | 112篇 |
金属工艺 | 37篇 |
机械仪表 | 11篇 |
建筑科学 | 37篇 |
能源动力 | 16篇 |
轻工业 | 76篇 |
水利工程 | 2篇 |
石油天然气 | 8篇 |
无线电 | 151篇 |
一般工业技术 | 182篇 |
冶金工业 | 1042篇 |
原子能技术 | 7篇 |
自动化技术 | 121篇 |
出版年
2021年 | 7篇 |
2020年 | 8篇 |
2018年 | 11篇 |
2017年 | 13篇 |
2016年 | 10篇 |
2014年 | 9篇 |
2013年 | 43篇 |
2012年 | 18篇 |
2011年 | 34篇 |
2010年 | 31篇 |
2009年 | 31篇 |
2008年 | 40篇 |
2007年 | 36篇 |
2006年 | 43篇 |
2005年 | 35篇 |
2004年 | 28篇 |
2003年 | 20篇 |
2002年 | 34篇 |
2001年 | 14篇 |
2000年 | 22篇 |
1999年 | 44篇 |
1998年 | 250篇 |
1997年 | 164篇 |
1996年 | 112篇 |
1995年 | 92篇 |
1994年 | 70篇 |
1993年 | 64篇 |
1992年 | 22篇 |
1991年 | 26篇 |
1990年 | 34篇 |
1989年 | 25篇 |
1988年 | 26篇 |
1987年 | 28篇 |
1986年 | 25篇 |
1985年 | 30篇 |
1984年 | 23篇 |
1983年 | 13篇 |
1982年 | 13篇 |
1981年 | 28篇 |
1980年 | 23篇 |
1979年 | 10篇 |
1978年 | 15篇 |
1977年 | 32篇 |
1976年 | 56篇 |
1975年 | 11篇 |
1974年 | 7篇 |
1973年 | 9篇 |
1972年 | 7篇 |
1967年 | 10篇 |
1966年 | 9篇 |
排序方式: 共有1819条查询结果,搜索用时 31 毫秒
1.
Magnetic resonance imaging of the pediatric airway 总被引:1,自引:0,他引:1
FL Rimell AM Shapiro MP Meza S Goldman S Hite B Newman 《Canadian Metallurgical Quarterly》1997,123(9):999-1003
2.
MG Newman 《Canadian Metallurgical Quarterly》1997,2(1):180-198
The design and implementation of clinical trials (CTs) carried out to evaluate antimicrobial and anti-infective drugs and devices are one of the most difficult challenges in contemporary periodontal research and product development. The overwhelming amount of evidence which has established a microbial etiology for periodontitis is the basis for developing and testing antimicrobial treatments. Well-designed antimicrobial CTs start with a carefully crafted hypothesis and a protocol which explicitly integrates the requirements of the patient, the clinician, the sponsor, and regulatory authorities. Surrogate variables for effectiveness must be clinically relevant, scientifically sound, and statistically valid. Currently, clinical attachment level measurements and alveolar bone assessments are accepted as proof of effectiveness. Indication and claim support of the antimicrobial product guide the design and implementation of the CT. Adverse microbiologic consequences, such as lack of antimicrobial susceptibility, wrong spectrum, incorrect dosage, non-compliance, and drug interference, must be monitored. Successful CTs balance a large group of variables used to screen, randomize, and assign subjects to experimental and control groups to ensure that prognostic and risk factors are properly accounted for. 相似文献
3.
4.
FL Kiselev 《Canadian Metallurgical Quarterly》1997,42(6):248-251
The migration of substances from rubber packaging materials into drug products can be significant with certain packaging materials in contact with organic solvent systems. Recommendations for testing drug products for leachables are continually evolving to address new developments. Testing packaging materials using simulated solvents is not always an acceptable protocol for the pharmaceutical industry. We describe a rational strategy for evaluation of the drug product for packaging extractables. A profile of the extractables from rubber packaging materials was made with a range of organic solvents and stress conditions to provide information on substances to target in the drug product. The drug product was evaluated to determine if the matrix would cause interferences that might inhibit detection of the found extractables. Analytical methods were selected based on these findings. The procedures were validated according to FDA guidelines. A stability program using time and storage conditions as variables provided information for acceptance criteria. This same strategy can be used on other types of pharmaceuticals and packaging materials. 相似文献
5.
SM Kornblau E Estey T Madden HT Tran S Zhao U Consoli V Snell G Sanchez-Williams H Kantarjian M Keating RA Newman M Andreeff 《Canadian Metallurgical Quarterly》1997,15(5):1796-1802
PURPOSE: Expression of the multidrug resistance gene (MDR1) p170 protein is frequent in leukemic blasts from patients with relapsed acute myelogenous leukemia (AML). A phase I study using the nonimmunosuppressive MDR1 blocker SDZ PSC-833 (PSC) in combination with mitoxantrone (MITO) and etoposide (VP) was performed. PATIENTS AND METHODS: Starting doses (LVL0) of MITO (3.25 mg/m2/d on days 1 and 3 to 6) and VP (210 mg/m2/d on days 1 and 3 to 5) were 40% of the maximal-tolerated dose (MTD) from a prior study. A 1.5-mg/kg loading dose of PSC was followed by a 120-hour continuous infusion of 10 mg/kg/d on days 2 to 6. Blood samples for PSC, MITO, and VP pharmacokinetics (PK) were taken on days 1 and 3, and samples for MDR1 expression were taken on day 0. RESULTS: Severe mucositis developed in all patients at LVL0; therefore, MITO and VP doses were reduced to 2.5 and 170 mg/m2 (LVL-1) for the next seven patients, and this dose proved to be MTD. All LVL0 and three LVL-1 patients had transient elevations in the serum bilirubin level to > or = 4 mg/dL. Serum creatinine level increased to greater than 2 mg/dL in one case. There were no other grade 3 or 4 nonhematologic toxicities observed. The peripheral blood was cleared of leukemia in three LVL0 and four LVL-1 patients. The marrow was cleared of leukemic cells in one LVL0 and five LVL-1 patients, and a significant reduction in marrow leukemic infiltrate was observed in eight of 10. No patient achieved complete remission (CR), and all died of progressive disease (n = 8) or infection (n = 2). MDR1 expression was detected by fluorescent-activated cell sorter (FACS) analysis in five of seven cases. An elevated MDR1 mRNA level was detected by quantitative polymerase chain reaction (Q-PCR) in six of eight cases studied. Clearing of leukemia cells from the marrow occurred in four of six MDR1-positive and one of three MDR1-negative patients. Despite the fact that LVL0 doses had to be reduced due to toxicity, coadministration of PSC did not produce a consistent effect on MITO PK; however, it did repeatedly lead to increased levels of VP in the serum. CONCLUSION: We conclude that PSC-MITO-VP is a tolerable regimen with antileukemic activity. Addition of PSC necessitated a 66% reduction in MITO and VP doses from a prior study without PSC. 相似文献
6.
7.
Hepatitis B virus (HBV) infection is a major health problem in the United States; in 1995, approximately 128,000 cases occurred. Transmission of HBV occurs primarily by blood exchange (eg, by shared needles during injection drug use) and by sexual contact. Persons infected early in life are much more likely to become chronically infected than those infected during adulthood: as many as 90% of infants infected perinatally develop chronic infection and up to 25% will die of HBV-related chronic liver disease as adults. Clinical signs of acute hepatitis occur in about 50% of infected adults but in only 5% of infected preschool-aged children. In the United States, hepatitis B vaccine is currently made by recombinant DNA technology using baker's yeast. Preexposure vaccination results in protective antibody levels in almost all infants and children (> 95%) and healthy adults younger than 40 years of age (> 90%). The most common adverse event following administration of hepatitis B vaccine is pain at the injection site, which occurs in 13% to 29% of adult and 3% to 9% of children. A comprehensive hepatitis B vaccination policy is now recommended that includes (1) routine infant vaccination; (2) catch-up vaccination of 11- to 12-year-olds who were not previously vaccinated; (3) catch-up vaccination of young children at high risk for infection; (4) vaccination of adolescents and adults based on lifestyle or environmental, medical, and occupational situations that place them at risk; and (5) prevention of perinatal HBV infection. 相似文献
8.
9.
10.
RA Newman JC Vidal LJ Viskatis J Johnson MA Etcheverry 《Canadian Metallurgical Quarterly》1993,11(2-3):151-159
Two purified animal venom toxins, crotoxin and cardiotoxin, have been combined to produce a unique natural product (VRCTC-310) currently under investigation as an antitumor agent by the National Cancer Institute. In vitro, it has demonstrated cytotoxic disease specificity and a unique mechanism of action when submitted to COMPARE analysis. In vivo, tolerance was developed to the neurotoxic properties of crotoxin which allowed comparison of several schedules of fixed and escalating daily i.m. doses to mice bearing s.c. Lewis Lung carcinoma. An 83% inhibition of tumor growth was achieved using an escalating dose schedule starting at 1.8 mg/kg and reaching 6.3 mg/kg/day on day 20. Although some irritation around the sites of i.m. injection was noted, animal weight loss was negligible and there were no other signs of adverse toxicity. This natural product represents a new, membrane interactive anticancer agent which produces a unique spectrum of cytotoxicity in vitro and which has demonstrated interesting in vivo antitumor efficacy. 相似文献